Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteer Safety Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00885989
What this trial is testing

Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers

Who this might be right for
Healthy
Solvay Pharmaceuticals 42
Early research (Phase 1)Study completedNCT05944848
What this trial is testing

CL-197 Capsules in Healthy Participants

Who this might be right for
HIV-1
Henan Genuine Biotech Co., Ltd. 44
Early research (Phase 1)Study completedNCT06623526
What this trial is testing

Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Yuhan Corporation 26
Early research (Phase 1)Study completedNCT02104648
What this trial is testing

A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 203
Early research (Phase 1)Study completedNCT06841315
What this trial is testing

A Varegacestat Hepatic Impairment Study

Who this might be right for
Healthy VolunteerHepatic Impairment (HI)
Immunome, Inc. 35
Early research (Phase 1)Study completedNCT03087942
What this trial is testing

Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects

Who this might be right for
Renal Insufficiency
Novartis Pharmaceuticals 45
Early research (Phase 1)Study completedNCT01477073
What this trial is testing

Multiple Dose FSH-GEX(TM) in Healthy Volunteers

Who this might be right for
Female Infertility
Glycotope GmbH 57
Early research (Phase 1)Study completedNCT04932005
What this trial is testing

DZD2269 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Dizal Pharmaceuticals 72
Early research (Phase 1)Study completedNCT01737866
What this trial is testing

Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency

Who this might be right for
Heart Failure
Cytokinetics 13
Early research (Phase 1)Study completedNCT04857866
What this trial is testing

Safety, Tolerability and PK of a Single Subcutaneous Injection of XmAb27564 in Healthy Volunteers

Who this might be right for
Safety in Healthy Volunteers
Xencor, Inc. 48
Large-scale testing (Phase 3)Study completedNCT03869866
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 290
Not applicableStudy completedNCT06059456
What this trial is testing

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Who this might be right for
Influenza Immunization (Healthy Volunteers)
Sanofi 2,078
Early research (Phase 1)Study completedNCT03446053
What this trial is testing

Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

Who this might be right for
Healthy VolunteersAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus Aureus+1 more
Intron Biotechnology, Inc. 33
Early research (Phase 1)Study completedNCT01951027
What this trial is testing

Phase I Study GX-G3 in Healthy Subjects

Who this might be right for
Healthy
Genexine, Inc. 53
Early research (Phase 1)Study completedNCT02148627
What this trial is testing

Safety Study of LY3041658 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 54
Early research (Phase 1)Study completedNCT02178254
What this trial is testing

Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects

Who this might be right for
Pseudomonas Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT04488705
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects

Who this might be right for
Healthy
Enterprise Therapeutics Ltd 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04928222
What this trial is testing

Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)

Who this might be right for
Basal Cell Carcinoma
SkinJect, Inc. 25
Early research (Phase 1)Study completedNCT06339788
What this trial is testing

Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Handok Inc. 40
Early research (Phase 1)Study completedNCT00757042
What this trial is testing

Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis

Who this might be right for
Atopic DermatitisHealthy Volunteers
Amgen 78
Next Page